Embody GLP‑1 Reviews 2026: Is It Legit? From $53 a Month

We earn a fee if you sign up through our link. It never changes the score. How we make money
How we checked Embody
We walked Embody’s sign-up up to the card form on Oct 27, 2026, read its terms and refund policy, and looked up each pharmacy it names in the FDA’s lists.



Commission is not an input. See the full score
Embody (Embody Meds) is an online program that sells compounded semaglutide and tirzepatide injections, with the doctor, the drug and the shipping in one monthly price. It suits you if you want a compounded GLP-1 at a low, flat rate and do not need a brand-name pen.
We rate it 9.6 out of 10, tier Excellent. Every fee is $0, it names its pharmacies, and over a first year of treatment it ranks 4 of the 45 compounded programs we track.
On a 12-month plan, Embody costs $53.27 a month for compounded semaglutide and $107.62 a month for compounded tirzepatide, billed up front as $588 and $1,188. Month to month, the prices are $79 and $129 every 4 weeks. The checkout says the rate you sign up at stays for the life of your plan.
What is Embody?
Embody is an online weight-loss program that sells compounded GLP-1 injections on a subscription. The provider consult, the medication and the delivery are all included in one monthly price.
Here is the process. You fill in an intake form on the site. A doctor from OpenLoop Health, a network of US-licensed physicians, reviews it and decides whether a GLP-1 suits you. If it does, the prescription goes to one of the compounding pharmacies Embody works with. The medication ships to your door for free, in 1-2 days. Refills continue on the same subscription, with a nursing team and provider messaging in between.
The menu has two drugs, both compounded and both weekly injections: semaglutide and tirzepatide. There is no brand-name option. Compounded GLP-1s are prepared by a pharmacy to a prescription, and they are not FDA-approved; the safety section explains what that means. To understand the drugs themselves, read our pages on compounded semaglutide and compounded tirzepatide. Embody serves every US state except Louisiana, and in Nebraska only patients 19 and over.
How much does Embody cost?
On a 12-month plan, Embody prices compounded semaglutide at $53.27 a month and compounded tirzepatide at $107.62 a month, with the doctor and the shipping included. On the monthly plan, which you can cancel at any time, the prices are $79 and $129 every 4 weeks. The membership fee, the consultation fee and the shipping fee are each $0. The table below has every plan, with what each one bills.
The checkout says "The price you see today is the price you pay forever", so a plan keeps the rate you sign up at. The main site says the rate depends on the plan you pick at checkout, from 4 to 52 weeks.
Embody does not bill insurance. Over a first year of treatment on its cheapest plan, Embody ranks 4 of the 45 compounded programs we track, against a median of $163.79 a month.
Embody semaglutide price
Compounded semaglutide costs $53.27 a month on a 12-month plan, billed as $588 for a 48-week supply. On the monthly plan, which you can cancel at any time, it costs $79 every 4 weeks. Both prices include the doctor, the medication and the shipping, with no membership or consultation fee.
The 3-month and 6-month plans are a commitment you pay for up front. Confirm your rate at checkout before you pay.
For scale, a pharmacy pays $871.12 for a Wegovy 1.7 mg pen package, effective September 23, 2026. That is an acquisition cost for the brand-name drug, not what a patient pays.
Embody tirzepatide price
Compounded tirzepatide costs $107.62 a month on a 12-month plan, billed as $1,188 for a 48-week supply. On the monthly plan, with no minimum term, it costs $129 every 4 weeks. Both prices include the doctor, the medication and free shipping.
The main site says pricing varies only by the plan you select at checkout, from 4 to 52 weeks. So treat $129 as the month-to-month price and $107.62 a month as the price of a year's lock.
For what tirzepatide is, read our compounded tirzepatide page.
The card is charged every 4 weeks, so a first year month to month is 13 charges: $1,027 for compounded semaglutide or $1,677 for compounded tirzepatide.
Last read Oct 26, 2026 from the provider’s own site. The page we read
Compare: compounded semaglutide programs, ranked · compounded tirzepatide programs, ranked · every program, ranked
Can you trust Embody?
Embody names its prescriber network, OpenLoop Health, and the four pharmacies that fill its prescriptions: Red Rock Compounding Pharmacy, Health Warehouse, Precision Medicine and Triad Rx. Embody itself has no FDA warning letter and no open flag, and it says plainly that its drugs are compounded. One of its pharmacies has an FDA record: Triad Rx received a warning letter on February 5, 2019, which the FDA closed out on May 3, 2023.
Embody says its pharmacies are "US based 503A compounding pharmacies". A 503A pharmacy compounds for a named patient on a prescription and is licensed by a state board. None of the four is a 503B outsourcing facility on the FDA's register, which is normal for that pharmacy type. The FDA still inspects 503A pharmacies and publishes what it finds; the safety section has what it found for these four.
The medical entity behind the service is Modern Metabolic Medicine. Each product page names the molecule and the form. Traceability scores 9 out of 10.
How does Embody work?
The care runs through a nursing team and a patient portal, not scheduled video visits. Embody advertises 24/7 specialist messaging, unlimited appointments, a personalized care plan and a metabolic report as part of the price. The prescriber sets your dose: "Our providers will do their best to match you with the dosage that best fits your needs and journey."
The terms state that Modern Metabolic Medicine "does not manufacture, dispense, or control the formulation of any medications" it prescribes. Embody does not state whether it asks for labs before or during treatment. Clinical care scores 10 out of 10.
Is Embody safe? FDA status and warning letters
Embody has no FDA warning letter and no open flag on its record. Two of its four pharmacies have an FDA record, which we matched on the addresses Embody lists, not on their names alone.
Triad Rx, at the Daphne, Alabama address Embody lists, received an FDA warning letter on February 5, 2019, for making sterile drugs under insanitary conditions. The FDA closed out the letter on May 3, 2023.
On July 31, 2026, the FDA issued a Form 483, a list of inspection observations, to Red Rock Pharmacy's site in Springville, Utah. Its observations include how the pharmacy tested its sterile filling process while filling semaglutide and tirzepatide lots. Embody lists Red Rock's St. George, Utah site and doesn't say which site fills its orders. Health Warehouse and Precision Medicine have no FDA action on the lists we check.
The bigger question with any compounded program is the drug itself. Compounded GLP-1s are prepared by a pharmacy to a prescription. They are not FDA-approved: the FDA doesn't review their safety, effectiveness or quality before they're sold, and they are not the same as Wegovy or Zepbound. Formulas can differ from one pharmacy to the next, and some add ingredients such as vitamin B12. Compounding pharmacies are licensed and inspected by state boards of pharmacy; outsourcing facilities (503B) also register with the FDA and are inspected by it. The FDA can issue warning letters when either breaks rules on safety or sterility.
Embody's intake pages carry a clinical note of their own: "For those taking Tirzepatide, we recommend switching to a non-oral contraceptive method or adding a barrier method of contraception for four weeks after initiation and for four weeks after each dose escalation."
For side effects, doses and who should not take these drugs, read our pages on semaglutide side effects and tirzepatide side effects, which quote the FDA labels. Safety scores 10 out of 10 on this record.
How to cancel Embody
It depends on the plan you chose. The monthly plans have no contract: "With Embody there are no contracts for our month to month pricing." The multi-month plans are a commitment: the terms say you "agree to the full commitment period selected", and the refund policy makes them non-refundable. To stop the next charge, the terms say "Cancellation requests must be received at least 72 hours prior to your next billing date in order to stop the next charge."
Refunds are narrow: you get one only if a provider finds you don't medically qualify, and then only for the unused part of your term, less the services already provided. The checkout page promises more: "If your provider can't approve your prescription you will receive a full refund." Consultation fees are not refunded. Medication that has been prescribed, compounded or shipped can't be returned or refunded.
So the trap is simple. Do not prepay $588 or $1,188 for 12 months unless you are sure you will stay on the drug for a year. If you have side effects, talk to your provider. Terms score 7.2 out of 10: the monthly plans are clean, the annual lock costs the rest.
On the sign-up form, the box agreeing to marketing calls and texts is already ticked; untick it if you don't want them.
From Embody’s refund policy page, read on Oct 26, 2026. Read it
What customers say about Embody
Embody publishes 11 testimonials on its offer page. Most give the pounds the writer lost; we don't repeat those figures, because one person's result doesn't show how well a program works. Several mention the support: "Having real support at every step made it easier to stay on track." Embody's own footer says that, for patient privacy, images representing the testimonials "may use models".
This site collects no independent reviews, and Embody is a newer platform with few reviews elsewhere. For what you will pay and what you sign, read the cost and cancel sections above.
How we scored Embody
Our score combines seven checks. Each one counts for a fixed share of the total, listed below. Commission is not an input.
- Price transparency: 10/10 (counts for 20% of the total score). Every fee is $0 and every price held, but the landing page omits the plan length behind its rates.
- Cost and value: 10/10 (counts for 15% of the total score). We price a first year of treatment on its cheapest plan for each drug, fees included, and compare it only with programs selling the same drug: it ranks 4 of 45 compounded programs we track, against a median of $163.79 a month.
- Medication and pharmacy traceability: 9/10 (counts for 15% of the total score). Four pharmacies named, with their addresses.
- Clinical access and oversight: 10/10 (counts for 15% of the total score). A named prescriber network and a stated wait time, but no lab policy.
- Safety and enforcement: 10/10 (counts for 20% of the total score). No warning letter against Embody and no open flag. One of its pharmacies, Triad Rx, had an FDA warning letter in 2019 that the FDA has closed out, and a closed-out letter costs no points. The Form 483 is not part of this check.
- Terms, commitment and refunds: 7.2/10 (counts for 10% of the total score). The monthly plans cancel anytime; the 12-month plans do not.
- Availability and fulfillment: 10/10 (counts for 5% of the total score). 49 states and free shipping.
The method is on our methodology page.
Embody vs WellMedr, Collective and YourEra
Embody alternatives
The three best-rated programs that serve the same need, with the price difference against Embody on every card.
We may earn a commission when you sign up through some links. It never changes our order or scores. How we make money
Which should you pick?
Embody FAQ
Embody names its doctor network, OpenLoop Health, and four 503A compounding pharmacies, and it has no FDA warning letter or open flag.12 It also states plainly that its drugs are compounded. One of its pharmacies, Triad Rx, had an FDA warning letter in 2019, since closed out.9 The pharmacy and record checks are in the trust section.
Embody costs $53.27 a month for compounded semaglutide and $107.62 a month for compounded tirzepatide on a 12-month plan, with no other fee.11 Month to month, it is $79 and $129 every 4 weeks.11 The full ladder is in the cost section.
No telehealth program is FDA approved; the FDA approves medications, not programs. Everything Embody prescribes is compounded semaglutide or tirzepatide, and compounded drugs are not FDA-approved.1 Embody sells no brand-name pen such as Wegovy or Zepbound. The FDA record is in the safety section.
Compounded semaglutide costs $53.27 a month on a 12-month plan and $79 every 4 weeks on the monthly plan.11 Both include the doctor and the shipping. See the cost section.
Embody's compounded tirzepatide is filled by the same four named 503A pharmacies, including Red Rock Compounding Pharmacy and Triad Rx, and compounded drugs are not FDA-approved.1 Embody itself has no FDA warning letter. Triad Rx had one in 2019, since closed out, and Red Rock's Springville site received a Form 483 in July 2026.910 It costs $129 every 4 weeks month to month, or $107.62 a month on a 12-month plan.11 See the safety section.
Who is behind this review
Editorial policy · How we review medically · Found an error? contact@glp1.health
Data sources
- 1.Embody home pageThe program’s own site, quoted verbatimEmbodyretrieved Oct 16, 2026↩“Flat locked in monthly pricing. $69/month Semaglutide or $119/month Tirzepatide”
- 2.Embody pricing pageThe program’s own site, quoted verbatimEmbodyretrieved Oct 16, 2026↩“Ozempic® is FDA-approved for type 2 diabetes treatment but may be prescribed for weight loss.”
- 3.Embody terms pageThe program’s own site, quoted verbatimEmbodyretrieved Oct 26, 2026↩“Modern Metabolic Medicine does not manufacture, dispense, or control the formulation of any medications prescribed as part of these services.”
- 4.Embody refund policy pageThe program’s own site, quoted verbatimEmbodyretrieved Oct 16, 2026↩“The decision to use compounded drugs is guided by the licensed provider's medical judgment, which is informed by a telehealth consultation and medical history.”
- 5.Embody websiteThe program’s own site, quoted verbatimEmbodyretrieved Oct 16, 2026↩“For those taking Tirzepatide, we recommend switching to a non-oral contraceptive method or adding a barrier method of contraception for four weeks after initiation and for four weeks after each dose escalation.”
- 6.
- 7.Compounded Semaglutide and Tirzepatide Products Use Unique Formulations but Efficacy and Safety Largely UnknownBelcourt J, Sapowadia A, White CM. Ann Pharmacother. 2026;60(9):902-906. doi:10.1177/10600280261421979Annals of Pharmacotherapy↩
- 8.Accuracy Considerations in Sterile CompoundingAkers MJ. Int J Pharm Compd. 2017;21(2):133-142. PMID: 28346209International Journal of Pharmaceutical Compounding↩
- 9.FDA warning letter to Triad Rx, Inc., Daphne, ALIssued February 5, 2019, to 26258 Pollard Road, Daphne, AL 36526. Closed out May 3, 2023US Food and Drug Administrationretrieved Oct 16, 2026↩
- 10.FDA compounding inspections, recalls and other actionsLists the Form 483 issued July 31, 2026 to CD Pharmacy LLC (dba Red Rock Pharmacy), Springville, UT, and the Triad Rx close-out of May 3, 2023US Food and Drug Administrationretrieved Oct 16, 2026↩
- 11.Embody checkout plan pagePrices for the monthly, 3-, 6- and 12-month plans with the BLACKFRIDAY code applied, shown after the intake; seen by our editorEmbodyretrieved Oct 27, 2026↩“Semaglutide Injection for only $99/month forever”
- 12.Embody sign-up form and checkoutThe sign-up form, plan cards and card form, read off the sign-up funnel up to the card formEmbodyretrieved Oct 27, 2026↩“If your provider can't approve your prescription you will receive a full refund.”
- 13.LegitScript certification lookupjoinem.co: CertifiedLegitScriptretrieved Oct 29, 2026
NADAC figures are pharmacy acquisition costs, not retail prices and not what you will pay. This content is educational and is not medical advice.



